<- Go home

Professional

[TWITTER] ToffCap

Added to YB: 2024-09-02

Pitch date: 2024-09-01

LFCR [bullish]

Lifecore Biomedical, Inc.

+55.35%

current return

Author Info

ToffCap are full-time fund managers finding undervalued opportunities and a reason why the price should (start to) move in the right direction. Sign up for their newsletter.

Company Info

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.

Market Cap

$220.6M

Pitch Price

$4.30

Price Target

25.00 (+274%)

Dividend

N/A

Sector

Life Sciences Tools and Services

Category

turnaround

Betting on a Rebound: Why Lifecore Biomedical Could Triple in Value

LFCR: CDMO with $40-50m EBITDA potential. Recent headwinds: no sale, delayed filings, debt issues, poor guidance. But capacity ramping, filings current, new management. $15-25 price target on reasonable multiples. High demand for CDMO assets. Current price <$5 offers intriguing risk/reward.

Read full article (1 min)